BackPrestige Consumer Healthcare Overview

Prestige Consumer Healthcare Current Assets

Track Prestige Consumer Healthcare's current assets ($430M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$431.48M
3.76% YoYΔ $-16.84M vs prior year quarter

Peer average

Loading

Prestige Consumer Healthcare Current Assets History

Loading

Prestige Consumer Healthcare vs. peers: Current Assets Comparison

Loading

Prestige Consumer Healthcare Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Prestige Consumer Healthcare (PBH) FAQ

The latest current assets for PBH is $430M as of March 2026. That compares with $450M in the prior-year period — down 3.8% year over year. Investors often review this figure alongside Prestige Consumer Healthcare's historical trend and sector peers before judging valuation or financial health.

Over the past year, PBH's current assets moved from $450M to $430M — a 3.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Prestige Consumer Healthcare's operating scale or balance-sheet position.

A current assets figure of $430M for PBH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PBH's current assets ($430M), review year-over-year change from $450M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Prestige Consumer Healthcare's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.